Non Small Cell Lung Cancer

Cancer Type:

Targeted Therapy, General Lung Cancer, Non Small Cell Lung Cancer, Immunotherapies

Disease Learning:

Case Based Panel Discussion - Metastatic Squamous NSCLC Low Tumor PD-L1 Frail Patient - Treatment?

Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss a frail patient with metastatic squamous NSCLC with low tumor PD-L1 expression, and the best treatment approach for this patient.

Cancer Journey:

Cancer Type:

Aging and Elderly, General Lung Cancer, Non Small Cell Lung Cancer, Tumor Marker Tests, Immunotherapies, Chemotherapy

Disease Learning:

Case Based Panel Discussion - Rapid Progression Adenocarcinoma High PD-L1 - How Do You Treat?

Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss treating a patient with rapidly progressing lung adenocarcinoma and high tumor PD-L1 expression.

Cancer Journey:

Cancer Type:

Non Small Cell Lung Cancer, Tumor Marker Tests

Disease Learning:

Lung Cancer Video Library - MET as a Target in Advanced NSCLC

Dr. Vamsidhar Velcheti with the Cleveland Clinic joined GRACE to discuss updates to our Lung Cancer Video Library. In this video, Dr. Velcheti discusses MET as a target in advanced non-small cell lung cancer.

Cancer Journey:

Cancer Type:

Non Small Cell Lung Cancer, Targeted Therapy

Disease Learning:

Lung Cancer Video Library 2017 - Liquid Biopsies for Broad Genomic Testing in Lung Cancer

Nathan Pennell, MD, PhD , Director of Lung Cancer Medical Oncology at the Cleveland Clinic Taussig Cancer Center in Cleveland Ohio discusses Liquid...

Cancer Journey:

Cancer Type:

General Lung Cancer, Non Small Cell Lung Cancer, Tumor Marker Tests

Disease Learning:

Articles

My Top 10 ASCO 2017 Lung Cancer Presentations

Over the next few days, about 30,000 oncologists and other cancer care professionals, along with a growing number of patient advocates, are...

Cancer Journey:

Cancer Type:

Non Small Cell Lung Cancer, Small Cell Lung Cancer

Disease Learning:

Clinical Trial Spotlight: Should a Third Generation EGFR Inhibitor be First Line Therapy for EGFR Mutation-Positive NSCLC?

Dr. Jack West introduces the question of whether third generation EGFR tyrosine kinase inhibitors osimertinib and rociletinib should be used as first line therapy rather than for acquired resistance, including discussing key clinical trials on the topic.

Cancer Journey:

Cancer Type:

Targeted Therapy, Clinical Trials, Molecular Testing, Non Small Cell Lung Cancer

Disease Learning:

Community Forum

Osimertinib

Mother-in-Law was diagnosed with NSCLC and after a blood biopsy, doctor is recommending Osimertinib. I tried searching on the main page, but it wasn'...

Cancer Journey:

Just Diagnosed

Cancer Type:

Lung Cancer, Drugs, Targeted Therapies - EGFR, First-line treatment, Non Small Cell Lung Cancer

Disease Learning:

Silibinin effective for brain metastases in lung cancer

This seems to be an option for everyone with brain metastases (inform your doctor as it is quite new) ) Here are links to research done in Spain in...

Cancer Journey:

Cancer Type:

Lung Cancer, General Lung Cancer, Radiation Therapy, Non Small Cell Lung Cancer

Disease Learning:

Osimertinib best after Afatinib ? (with no result from liquid biopsies)

My mum (73years,IVstage,small meta in lymph nodes,EGFR+,exon18,G719X), was for 21 months on 1st line Afatinib (first 40% reduction, last three months...

Cancer Journey:

Cancer Type:

Lung Cancer, General Lung Cancer, Targeted Therapies - EGFR, Non Small Cell Lung Cancer

Disease Learning:

Osimertinib (Tagrisso) with dexamethasone

Is anyone on Tagrisso (osimertinib) taking or took dexamethasone? I want to start my mum on osimertinib, but she is taking dexamethasone for brain...

Cancer Journey:

Cancer Type: